• P-ISSN 0973-7200 E-ISSN 2454-8405
  • Follow us

Journal of Pharmaceutical Research


Journal of Pharmaceutical Research

Year: 2022, Volume: 21, Issue: 4, Pages: 95-104

Systematic Review

Type-2 Diabetes Mellitus: A Review of Current Trends


Diabetes mellitus type 2 is a chronic metabolic condition whose incidence has been continuously growing around the world. As a result of this tendency, it is quickly becoming an epidemic in some parts of the world, with the number of individuals affected anticipated to double in the next decade as the world's population ages, adding to the already existing load on healthcare providers, particularly in poor developing countries. World Health Organization (WHO) guidelines are still used for screening and diagnosis, which include both clinical and laboratory characteristics. There is currently no cure for the disease; however, therapy options include lifestyle changes, obesity management, oral hypoglycemic medications, and insulin sensitizers such as metformin, a biguanide that reduces insulin resistance which is used as first line medication especially for obese patients. The traditional herbal medicine like garlic, neem, bitter gourd, aloe vera, onion, methi, amla, jamun, baheda etc. are also used for the treatment of the diabetes. Other effective medication includes non-sulfonylurea secretagogues, thiazolidinediones, alpha glucoside inhibitors, and insulin. Recent research into the biology of type 2 diabetes has led to the development of new medications such as glucagon-like peptide 1 analogues: dipeptidyl peptidase inhibitors, sodium glucose cotransporter 2 inhibitors, and 11-hydroxysteroid dehydrogenase 1 inhibitors, insulin releasing glucokinase activators. The novel drug delivery improves the treatment of diabetes by the inhaled insulin.


Keywords: Type 2 diabetes mellitus, Diabetes complications, Diabetes diagnosis, Diabetes management, Antidiabetic newer drugs, Antidiabetic herbal drugs


  1. Kumar CR. Basic Pathology (5). (pp. 569-587) Bangalore. Prism Book Private Limited. 1992.
  2. Waugh A, Grant A. Ross & Wilson Anatomy and Physiology in Health and Illness (11). (pp. 227-229Churchill Livingstone Elsevier. 2010.
  3. Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE. Defective regulatory and effector T cell functions in patients with FOXP3 mutationsJournal of Clinical Investigation2006;116(6):17131722. Available from: https://doi.org/10.1172%2FJCI25112
  4. Wassmuth R, Lernmark Å. The genetics of susceptibility to diabetesClinical Immunology and Immunopathology1989;53(3):358399. Available from: https://doi.org/10.1016/0090-1229(89)90002-0
  5. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatmentThe Lancet2001;358(9277):221229. Available from: https://doi.org/10.1016/s0140-6736(01)05415-0
  6. Jun SK, Yoon YW. A new look at viruses in type 1 diabetesDiabetes Metabolism Research and Reviews2002;19(1):831. Available from: https://doi.org/10.1002/dmrr.337
  7. Jecob LS, P. Pharmacology (The National medical series for independent study) (3). (pp. 221-225) Hong Kong, London. 1987.
  8. Tripathi KD. Essential medicals pharmacology (7). (pp. 258-281Jaypee brothers medical publishers . 2013.
  9. Harris MI. Undiagnosed NIDDM: Clinical and Public Health IssuesDiabetes Care1993;16(4):642652. Available from: https://doi.org/10.2337/diacare.16.4.642
  10. Diagnosis and Classification of Diabetes MellitusDiabetes Care2014;37(Supplement_1):S81S90. Available from: https://doi.org/10.2337/dc14-S081
  11. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodiesDiabetes1996;45(7):926933. Available from: https://doi.org/10.2337/diab.45.7.926
  12. Kahn CR, Lecture B. Insulin action, diabetogenes, and the cause of type II diabetesDiabetes1994;43(8):10661084. Available from: https://doi.org/10.2337/diab.43.8.1066
  13. Paul RR. Antagonist: diabetes and insulin resistance--philosophy, science, and the multiplier hypothesisThe Journal of laboratory and clinical medicine1995;125(5):560564. Available from: https://pubmed.ncbi.nlm.nih.gov/7738421/
  14. DGS, DG. Greenspan’s Basic & Clinical Endocrinology (9). The McGraw-Hill Companies. 2011.
  15. Barrett KE, Barman SM, Brooks HL, Yuan JXJ. Ganong’s Review of Medical Physiology (24). 2012.
  16. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper’s Illustrated Biochemistry (29). (pp. 978-985McGraw-Hill Medical. 2012.
  17. Bloom A, Hayes TM, Gamble DR. Register of newly diagnosed diabetic childrenBr Med J1975;3(5983):580583.
  18. Alemu S, Dessie A, Seid E, Bard E, Lee PT, Trimble ER, et al. Insulin-requiring diabetes in rural Ethiopia: should we reopen the case for malnutrition-related diabetes? Diabetologia2009;52(9):18421845. Available from: https://doi.org/10.1007/s00125-009-1433-5
  19. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030Diabetes Care2004;27(5):10471053. Available from: https://doi.org/10.2337/diacare.27.5.1047
  20. Gupta OP, Joshi MH, Dave SK. Prevalence of diabetes in IndiaAdv Metab Disord1978;9:147165. Available from: https://doi.org/10.1016/B978-0-12-027309-6.50013-6
  21. Ripsin CM, Kang H, Urban RJ. Management of blood glucose in type 2 diabetes mellitusAm Fam Physician2009;79(1):2936. Available from: https://pubmed.ncbi.nlm.nih.gov/19145963/
  22. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in womenN Engl J Med2001;345(11):790797. Available from: https://doi.org/10.1056/nejmoa010492
  23. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome--a new worldwide definitionLancet2005;366(9491):10591062. Available from: https://doi.org/10.1016/s0140-6736(05)67402-8
  24. Powers AC. Diabetes mellitus. In: Fauci AS, Braunwauld E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al., eds. Harrison’s Principles of Internal Medicine (17). (pp. 2275-2304) 2008.
  25. Sampson UK, Linton MF, Fazio S. Are statins diabetogenic? Curr Opin Cardiol2011;26(4):342349. Available from: https://doi.org/10.1097%2FHCO.0b013e3283470359
  26. Izzedine H, Launay-Vacher V, Deybach C, Bourry E, Barrou B, Deray G. Drug-induced diabetes mellitusExpert Opin Drug Saf2005;4(6):10971109. Available from: https://doi.org/10.1517/14740338.4.6.1097
  27. Adeyinka A, Kondamudi NP. Hyperosmolar Hyperglycemic Syndrome. In: StatPearlsStatPearls Publishing. 2022.
  28. Kobayashi S, Liang Q. Autophagy and mitophagy in diabetic cardiomyopathyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease2015;1852(2):252261. Available from: https://doi.org/10.1016/j.bbadis.2014.05.020
  29. Chiniwala N, Jabbour S. Management of diabetes mellitus in the elderlyCurrent Opinion in Endocrinology2011;18(2):148152. Available from: https://doi.org/10.1097/med.0b013e3283444ba0
  30. Asif AH, Nanjundan PK, Basavarajappa GM, Sreeharsha N. Uma Chandur and Teeka Srinivasasetty Roopashree. Insulin Resistance Modulation with Lifestyle Modification - Proof of Concept - Study in RatsIndian Journal of Pharmaceutical Education and Research2020;54(4):9991006. Available from: https://doi.org/10.5530/ijper.54.4.173
  31. Collier CA, Bruce CR, Smith AC, Lopaschuk G, Dyck DJ. Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscleAm J Physiol Endocrinol Metab2006;291(1):E182E189. Available from: https://doi.org/10.1152/ajpendo.00272.2005
  32. Staa TV, Abenhaim L, Monette J. Rates of hypoglycemia in users of sulfonylureasJ Clin Epidemiol1997;50(6):735741. Available from: https://doi.org/10.1016/S0895-4356(97)00024-3
  33. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureasArchives of Internal Medicine1997;157(15):16811686. Available from: https://pubmed.ncbi.nlm.nih.gov/9250229/
  34. Fuhlendorff J, Rorsman P, Kofod H, Brand CL, Rolin B, Mackay P, et al. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processesDiabetes1998;47(3):345351. Available from: https://doi.org/10.2337/diabetes.47.3.345
  35. Yki-Järvinen H. 47.Yki-Järvinen H. ThiazolidinedionesN Engl J Med2004;351(11):11061124. Available from: https://doi.org/10.1056/nejmra041001
  36. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in AsiaLancet2006;368(9548):16811689. Available from: https://doi.org/10.1016/s0140-6736(06)69703-1
  37. Martin JH, Deacon CF, Gorrell MD, Prins JB. Incretin-based therapies--review of the physiology, pharmacology and emerging clinical experienceIntern Med J2011;41(4):299307. Available from: https://doi.org/10.1111/j.1445-5994.2011.02439.x
  38. Pratley RE, Salsali A. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetesCurr Med Res Opin2007;23(4):919950. Available from: https://doi.org/10.1185/030079906x162746
  39. Burge MR, Schade DS. INSULINSEndocrinology and Metabolism Clinics of North America1997;26(3):575598. Available from: https://doi.org/10.1016/s0889-8529(05)70268-1
  40. Cameron CG, Bennett HA. Cost-effectiveness of insulin analogues for diabetes mellitusCanadian Medical Association Journal2009;180(4):400407. Available from: https://doi.org/10.1503%2Fcmaj.081180
  41. Tahrani AA, Bailey CJ, Prato D, Barnett S, AH. Management of type 2 diabetes: new and future developments in treatmentLancet2011;378(9786):182197. Available from: https://doi.org/10.1016/s0140-6736(11)60207-9
  42. Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetic potentialJ Ethnopharmacol2002;81(1):81100. Available from: https://doi.org/10.1016/S0378-8741(02)00059-4
  43. Seth SD, Sharma B. Medicinal plants in IndiaIndian J Med Res2004;120(1):911. Available from: https://pubmed.ncbi.nlm.nih.gov/15299226/
  44. Li WL, Zheng HC, Bukuru J, Kimpe ND. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitusJ Ethnopharmacol2004;92(1):121. Available from: https://doi.org/10.1016/j.jep.2003.12.031
  45. Wadood A, Wadood N, Shah SA. Effects of Acacia arabica and Caralluma edulis on blood glucose levels of normal and alloxan diabetic rabbitsJ Pak Med Assoc1989;39(8):208212.
  46. Roman-Ramos R, Flores-Saenz JL, Alarcon-Aguilar FJ. Anti-hyperglycemic effect of some edible plantsJournal of Ethnopharmacology1995;48(1):2532. Available from: https://doi.org/10.1016/0378-8741(95)01279-m
  47. Kumari K, Mathew BC, Augusti KT. Antidiabetic and hypolipidemic effects of S-methyl cysteine sulfoxide isolated from Allium cepa LinnIndian J Biochem Biophys1995;32(1):4954. Available from: https://pubmed.ncbi.nlm.nih.gov/7665195/
  48. Sheela CG, Augusti TK. Antidiabetic effects of S-allyl cysteine sulphoxide isolated from garlic Allium sativum LinnIndian Journal of Experimental Biology1992;30:523526. Available from: https://pubmed.ncbi.nlm.nih.gov/1506036/
  49. Ali L, KalamKhanHassan M, MosihuzzamanNaharet al. Characterization of the hypoglycemic effects of Trigonella foenum graecum seedPlanta Medica1995;61(4):358360. Available from: https://doi.org/10.1055/s-2006-958100
  50. Al-Awadi FM, Gumaa KA. Studies on the activity of individual plants of an antidiabetic plant mixtureActa Diabetol Lat 1987;24(1):3741. Available from: https://doi.org/10.1007/bf02732051
  51. Ajabnoor MA. Effect of aloes on blood glucose levels in normal and alloxan diabetic miceJournal of Ethnopharmacology1990;28(2):215220. Available from: https://doi.org/10.1016/0378-8741(90)90031-n
  52. Davis RH, Maro NP. Aloe vera and gibberellins, Anti-inflammatory activity in diabetesJ. Am. Pediat. Med. Assoc1989;79(1):2426. Available from: https://doi.org/10.7547/87507315-79-1-24
  53. Chattopadhyay RR, Chattopadhyay RN, Nandy AK, Poddar G, Maitra SK. Preliminary report on antihyperglycemic effect of fraction of fresh leaves of Azadiracta indica (Beng neem) Bull. Calcutta. Sch. Trop. Med1987;35:2933.
  54. Chattopadhyay RR, Chattopadhyay RN, Nandy AK, Poddar G, Maitra SK. The effect of fresh leaves of Azadiracta indica on glucose uptake and glycogen content in the isolated rat hemidiaphragmBull. Calcutta. Sch. Trop. Med1987;35:812. Available from: https://www.scienceopen.com/document?vid=12408c04-deca-4427-9c72-81d6b188c0af
  55. Biswas K, Chattopadhyay I, Banerjee RK, Bandyopadhyay U. Biological activities and medicinal properties of neem (Azadiracta indica) Curr. Sci2002;82(11):13361345. Available from: https://www.jstor.org/stable/24106000
  56. Ganji SR, Mahboubeh R, Hamed K, Kumar P, Kumar D, Pradeep K, et al. Antinociceptive Effect of Terminalia bellirica in Diabetic Peripheral Neuropathy: a Comparison with Fluoxetin, Imipramine and QuercetinLat Am J Pharm2012;31(4):520525.
  57. Kohli S, Kumar PN. Combined effect of Coccinia indica leaf extract with acarbose in type II diabetes induced neuropathy in ratsJ. Innov. Pharm. Biol. Sci2014;2014(1):7787.
  58. Premkumar N, Annamalai AR, Thakur &RS. Antinociceptive property of Emblica officinalis Gaertn (Amla) in high fat diet - fed/low dose streptozotocin induced diabetic neuropathy in ratsIndian Journal of Experimental Biolpgy2009;47(9):737742. Available from: https://pubmed.ncbi.nlm.nih.gov/19957886/
  59. Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trialLancet2010;375(9733):22442253. Available from: https://doi.org/10.1016/s0140-6736(10)60632-0



© 2022 Published by Krupanidhi College of Pharmacy. This is an open-access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/


Subscribe now for latest articles and news.